Revive Therapeutics Ltd. (RVVTF)
OTCMKTS · Delayed Price · Currency is USD
0.0144
+0.0004 (2.86%)
Aug 26, 2025, 3:39 PM EDT
Revive Therapeutics Market Cap
Revive Therapeutics has a market cap or net worth of $4.68 million as of August 26, 2025. Its market cap has increased by 52.53% in one year.
Market Cap
4.68M
Enterprise Value
4.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 9, 2014, Revive Therapeutics's market cap has decreased from 6.99M to 4.68M, a decrease of -33.06%. That is a compound annual growth rate of -3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 4.68M | 60.83% |
| Dec 31, 2024 | 2.91M | -64.27% |
| Dec 29, 2023 | 8.14M | -70.50% |
| Dec 30, 2022 | 27.61M | -67.81% |
| Dec 31, 2021 | 85.75M | -26.85% |
| Dec 31, 2020 | 117.22M | 3,399.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |